Junichiro Watanabe

5.8k total citations
126 papers, 1.5k citations indexed

About

Junichiro Watanabe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Junichiro Watanabe has authored 126 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 39 papers in Pulmonary and Respiratory Medicine and 24 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Junichiro Watanabe's work include HER2/EGFR in Cancer Research (34 papers), Cancer Treatment and Pharmacology (31 papers) and Advanced Breast Cancer Therapies (15 papers). Junichiro Watanabe is often cited by papers focused on HER2/EGFR in Cancer Research (34 papers), Cancer Treatment and Pharmacology (31 papers) and Advanced Breast Cancer Therapies (15 papers). Junichiro Watanabe collaborates with scholars based in Japan, United States and South Korea. Junichiro Watanabe's co-authors include Takayoshi Uematsu, Masako Kasami, Kaoru Takahashi, Yukiko Tadokoro, Hiroji Iwata, Haruki Kondo, Takashi Sugino, Takeshi Aramaki, Toshiaki Saeki and Naoki Morimoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Junichiro Watanabe

115 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichiro Watanabe Japan 22 654 471 382 279 220 126 1.5k
Allyson J. Ocean United States 18 1.1k 1.7× 361 0.8× 496 1.3× 205 0.7× 240 1.1× 81 1.9k
Hubing Wu China 21 493 0.8× 547 1.2× 338 0.9× 272 1.0× 119 0.5× 100 1.4k
Zhimin Shao China 22 1.1k 1.8× 290 0.6× 557 1.5× 557 2.0× 142 0.6× 90 1.8k
C. Cuvier France 19 629 1.0× 594 1.3× 206 0.5× 668 2.4× 191 0.9× 49 1.6k
Akihiko Osaki Japan 23 747 1.1× 325 0.7× 283 0.7× 528 1.9× 155 0.7× 116 1.7k
Samuele Massarut Italy 21 558 0.9× 316 0.7× 238 0.6× 794 2.8× 308 1.4× 67 1.5k
Peter Ang Singapore 21 730 1.1× 161 0.3× 225 0.6× 214 0.8× 110 0.5× 57 1.6k
Paul Richards United States 20 869 1.3× 203 0.4× 266 0.7× 342 1.2× 438 2.0× 42 1.4k
Roberto Carmagnani Pestana United States 17 547 0.8× 160 0.3× 279 0.7× 192 0.7× 125 0.6× 52 1.1k
Sharad Ghamande United States 22 770 1.2× 127 0.3× 230 0.6× 216 0.8× 185 0.8× 114 1.7k

Countries citing papers authored by Junichiro Watanabe

Since Specialization
Citations

This map shows the geographic impact of Junichiro Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichiro Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichiro Watanabe more than expected).

Fields of papers citing papers by Junichiro Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichiro Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichiro Watanabe. The network helps show where Junichiro Watanabe may publish in the future.

Co-authorship network of co-authors of Junichiro Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Junichiro Watanabe. A scholar is included among the top collaborators of Junichiro Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichiro Watanabe. Junichiro Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Horimoto, Yoshiya, et al.. (2024). Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgery. Japanese Journal of Clinical Oncology. 54(5). 556–561. 1 indexed citations
3.
Horimoto, Yoshiya, Hidetaka Eguchi, Katsuya Nakai, et al.. (2023). BRCAness of brain lesions reflects a worse outcome for patients with metastatic breast cancer. Breast Cancer Research and Treatment. 203(1). 49–55. 1 indexed citations
4.
Horimoto, Yoshiya, Kaori Denda‐Nagai, Haruhiko Fujihira, et al.. (2023). Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer. Scientific Reports. 13(1). 5281–5281. 5 indexed citations
5.
Ishigame, Teruhide, Ryo Okada, Yasuhide Kofunato, et al.. (2023). Tissue-Engineered Hepatocyte Sheets Supplemented with Adipose-Derived Stem Cells. Tissue Engineering Part A. 29(13-14). 384–396. 2 indexed citations
6.
7.
Shimomura, Akihiko, Toshimi Takano, Shunji Takahashi, et al.. (2022). Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pharmacokinetics in HER2‐Positive or HER2‐Low Metastatic/Unresectable Breast Cancer. Clinical Pharmacology & Therapeutics. 113(1). 160–169. 11 indexed citations
8.
Horimoto, Yoshiya, et al.. (2022). Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer. Breast Cancer Research and Treatment. 196(2). 291–298. 12 indexed citations
9.
Uematsu, Takayoshi, Kazuaki Nakashima, Takanori Kawabata, et al.. (2021). Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy. Radiology. 299(1). 53–62. 37 indexed citations
10.
11.
Futagami, Masayuki, et al.. (2019). Adenocarcinoma of the cervix: its prognosis and difficult pathological diagnosis. European Journal of Gynaecological Oncology. 40(5). 728–733. 1 indexed citations
12.
Watanabe, Junichiro, Yoshinori Ito, Toshiaki Saeki, et al.. (2017). Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer. In Vivo. 31(3). 493–500. 18 indexed citations
13.
Watanabe, Junichiro, et al.. (2017). Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up. Breast Cancer Research and Treatment. 162(1). 169–179. 28 indexed citations
14.
Iwata, Hiroji, Norikazu Masuda, Daigo Yamamoto, et al.. (2017). Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 162(3). 501–510. 10 indexed citations
15.
Niikura, Naoki, Akihiko Shimomura, Masataka Sawaki, et al.. (2017). Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis. Breast Cancer Research and Treatment. 167(1). 81–87. 20 indexed citations
16.
Watanabe, Junichiro, Takuma Hayashi, Yukiko Tadokoro, S. Nishimura, & Kaoru Takahashi. (2017). Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institution. Breast Cancer Research and Treatment. 166(3). 911–917. 10 indexed citations
17.
Marubashi, Shigeru, Akira Kenjo, Takao Tsuchiya, et al.. (2016). M1 macrophage infiltrations and histological changes in the liver after portal vein embolization using fibrinogen and OK432 in the rat. Cellular Immunology. 303. 66–71. 1 indexed citations
18.
Watanabe, Junichiro, et al.. (2010). [Sedation used during colonoscopies at the Peruvian-Japanese policlinic. Their relationship with quality indicators].. PubMed. 30(1). 40–5. 3 indexed citations
19.
Kondo, Haruki, et al.. (2001). Pure Red Cell Aplasia Associated with Parvovirus B19 Infection in T-large Granular Lymphocyte Leukemia. Leukemia & lymphoma. 42(6). 1439–1443. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allyson J. Ocean Breakdown of academic impact, for papers by Hubing Wu Breakdown of academic impact, for papers by Zhimin Shao Breakdown of academic impact, for papers by C. Cuvier Breakdown of academic impact, for papers by Akihiko Osaki Breakdown of academic impact, for papers by Samuele Massarut Breakdown of academic impact, for papers by Peter Ang Breakdown of academic impact, for papers by Paul Richards Breakdown of academic impact, for papers by Roberto Carmagnani Pestana Breakdown of academic impact, for papers by Sharad Ghamande
Rankless by CCL
2026